Cipla shines in gloomy pharma pack, biggest beneficiary of faster approvals
21 Nov 2017 //
BUSINESS-STANDARD
Cipla gets USFDA nod to market generic version of cancer drug Dacogen
20 Nov 2017 //
BUSINESS-STANDARD
21 Nov 2017 //
BUSINESS-STANDARD
20 Nov 2017 //
BUSINESS-STANDARD